Hana Pharm Co., Ltd. (293480.KS) KSC
Currency In KRW
- General
- Statistics
- Historical Data
- Profile
- Financials
Hana Pharm Co., Ltd.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
730
First IPO Date
October 02, 2018
Key Executives
| Name | Title | Pay | Year Born |
| Taehong Choi | Pres, Chief Executive Officer & Director | 0 | N/A |
| Elia Cho | Director of Global Department & Director | 0 | N/A |
| Hong-Joo Yun | Director of Bus. Department, Chief Financial Officer & Director | 0 | N/A |
Description
Hana Pharm Co., Ltd. is a pharmaceutical enterprise that manufactures and supplies a diverse range of medicinal goods to both domestic South Korean and international markets. Its comprehensive product line covers various therapeutic categories, such as anesthetics, potent narcotic pain relievers, anti-nausea agents, muscle relaxants, and treatments targeting the cardiovascular, endocrine, gastrointestinal, respiratory, and central nervous systems. Furthermore, the company offers antibiotics, dermatological preparations, urological medications, osteoporosis therapies, and medications for pain, fever, and inflammation. The firm was established in 1958 and has its corporate headquarters located in Seoul, South Korea.